tiprankstipranks
Trending News
More News >
Infant Bacterial Therapeutics (DE:9IB)
:9IB
Germany Market
Advertisement

Infant Bacterial Therapeutics AB (9IB) Technical Analysis

Compare
4 Followers

Summary of all the Indicators

Overall Consensus
Sell
3Bullish
6Neutral
13Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Infant Bacterial Therapeutics’s (9IB) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Infant Bacterial Therapeutics is a Sell.
Infant Bacterial Therapeutics’s (9IB) 20-Day exponential moving average is 4.48, while Infant Bacterial Therapeutics’s (9IB) share price is €4.41, making it a Sell.
Infant Bacterial Therapeutics’s (9IB) 50-Day exponential moving average is 4.57, while Infant Bacterial Therapeutics’s (9IB) share price is €4.41, making it a Sell.

Infant Bacterial Therapeutics AB (9IB) Pivot Points

Aug 10, 2025, 11:30 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.20
4.30
4.37
4.48
4.55
4.65
4.72
Fibonacci
4.30
4.37
4.41
4.48
4.55
4.59
4.65
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Infant Bacterial Therapeutics AB (9IB) Moving Averages

Aug 10, 2025, 11:30 PM
Period
Simple
Exponential
MA5
4.48Sell
4.46Sell
MA10
4.51Sell
4.48Sell
MA20
4.44Sell
4.48Sell
MA50
4.65Sell
4.57Sell
MA100
4.65Sell
4.56Sell
MA200
4.20Buy
4.45Sell
Infant Bacterial Therapeutics’s (9IB) 10-Day exponential moving average is 4.48, while Infant Bacterial Therapeutics’s (9IB) share price is €4.41, making it a Sell.
Infant Bacterial Therapeutics’s (9IB) 100-Day exponential moving average is 4.56, while Infant Bacterial Therapeutics’s (9IB) share price is €4.41, making it a Sell.
Infant Bacterial Therapeutics’s (9IB) stock price is €4.41 and Infant Bacterial Therapeutics’s (9IB) 50-day simple moving average is 4.65, creating a Sell signal.
Infant Bacterial Therapeutics’s (9IB) stock price is €4.41 and Infant Bacterial Therapeutics’s (9IB) 100-day simple moving average is 4.65, creating a Sell signal.
Infant Bacterial Therapeutics’s (9IB) stock price is €4.41 and Infant Bacterial Therapeutics’s (9IB) 200-day simple moving average is 4.20, creating a Buy signal.

Infant Bacterial Therapeutics AB (9IB) Technical Indicators

Aug 10, 2025, 11:30 PM
Name
Value
Implied Action
RSI (14)
45.39
Neutral
STOCH (9,6)
26.67
Neutral
STOCHRSI (14)
43.10
Neutral
MACD (12,26)
-0.02
Sell
ADX (14)
21.11
Neutral
Williams %R
-69.79
Buy
CCI (14)
-21.84
Neutral
ATR (14)
0.15
-
Ultimate Oscillator
33.50
Neutral
ROC
3.52
Buy
Infant Bacterial Therapeutics’s (9IB) Relative Strength Index (RSI) is 45.39, creating a Neutral signal.
Infant Bacterial Therapeutics’s (9IB) Trend Strength Indicator (ADX) is 21.11, creating a Neutral signal.
Infant Bacterial Therapeutics’s (9IB) Commodity Channel Index (CCI) is -21.84, creating a Neutral signal.
Infant Bacterial Therapeutics’s (9IB) Price Rate of Change (ROC) is 3.52, creating a Buy signal.

FAQ

Is 9IB a Buy, Hold, or Sell?
Based on 9IB’s technical indicators, 9IB is a Sell.
    What is 9IB’s RSI (14)?
    9IB’s RSI (14) is 45.39, which suggests 9IB is a Neutral.
      What is 9IB’s MACD?
      9IB’s MACD is -0.02, which suggests 9IB is a Sell.
        What is 9IB’s 5-day moving average?
        9IB’s 5-day moving average is 4.48, which suggests 9IB is a Sell.
          What is 9IB’s 20-day moving average?
          9IB 20-day moving average is 4.44, which suggests 9IB is a Sell.
            What is 9IB’s 50-day moving average?
            9IB’s 50-day moving average is 4.65, which suggests 9IB is a Sell.
              What is 9IB’s 200-day moving average?
              9IB’s 200-day moving average is 4.20, which suggests 9IB is a Buy.
                What is 9IB’s Williams % R (14)?
                9IB’s Williams % R (14) is -69.79, which suggests 9IB is a Buy.
                  What is 9IB’s CCI (14)?
                  9IB’s CCI (14) is -21.84, which suggests 9IB is a Neutral.
                    What is the share price of Infant Bacterial Therapeutics?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis